CVACCureVac N.V.

Nasdaq curevac.com


$ 2.44 $ -0.13 (-5.06 %)    

Thursday, 18-Apr-2024 15:59:59 EDT
QQQ $ 422.80 $ -2.43 (-0.57 %)
DIA $ 377.76 $ 0.39 (0.1 %)
SPY $ 499.54 $ -1.03 (-0.21 %)
TLT $ 88.82 $ -0.45 (-0.5 %)
GLD $ 220.32 $ 0.75 (0.34 %)
$ 2.44
$ 2.54
$ 0.00 x 0
$ 0.00 x 0
$ 2.44 - $ 2.54
$ 2.44 - $ 12.36
712,935
na
475.69M
$ 1.51
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 guggenheim-reiterates-neutral-on-curevac

Guggenheim analyst Evan Wang reiterates CureVac (NASDAQ:CVAC) with a Neutral.

 curevac-gsk-partner-release-data-on-influenza-vaccine-study

CureVac reveals Phase 2 interim data for its seasonal influenza vaccine in collaboration with GSK. Results show broad antigen c...

Core News & Articles

CureVac N.V. (NASDAQ:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines b...

 curevac-disclosed-ceo-alexander-zehnder-recently-purchased-50000-common-shares-of-curevac-stock

-SEC Filing

 why-biopharmaceutical-player-curevac-shares-are-rising-today

CureVac N.V. (NASDAQ: CVAC) shares are trading higher on Friday.

 why-compugen-shares-are-trading-higher-by-over-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with t...

 why-is-covid-19-vaccine-player-curevac-stock-plummeting-today

A German court has invalidated a patent central to CureVac N.V's (NASDAQ: CVAC) lawsuit against BioNTech SE (NASDAQ: BNTX) ...

 bluebird-bio-vertex-energy-and-other-big-stocks-moving-lower-on-tuesday

U.S. stocks traded higher, with the Dow Jones index gaining around 150 points on Tuesday. Shares of bluebird bio, Inc. (NASDA...

Core News & Articles

Validity of CureVac patent EP 1 857 122 B1 denied by German Federal Patent Court after nullity action filed by BioNTech SEDecis...

Core News & Articles

- Reuters

 acuitas-challenges-curevac-in-legal-tussle-over-covid-19-vaccine-technology

Biotech company Acuitas Therapeutics has filed a lawsuit in Virginia federal court against Germany-based CureVac SE (NASDAQ: CV...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 curevac-q3-sales-1796m-miss-1800m-estimate-pre-tax-loss-was-530m

CureVac (NASDAQ:CVAC) reported quarterly sales of $17.96 million which missed the analyst consensus estimate of $18.00 million ...

Core News & Articles

COVID-19 Phase 2 clinical trial fully enrolledStudy compares mono- and bivalent vaccine candidates against licensed comparator ...

 stocks-that-hit-52-week-lows-on-thursday

  During Thursday's session, 406 companies made new 52-week lows.

 why-carmax-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its p...

Core News & Articles

CureVac N.V. (NASDAQ:CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION